SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

Beta Bionics Price Target Raised to $28.00/Share From $23.00 by Truist Securities

Ratings actions from Benzinga

BBNX

Related stories